Haleon plc Form 6-K Filing Summary

Haleon plc announced on June 15, 2026, the purchase and cancellation of 565,285 ordinary shares of £0.01 each as part of its share buyback program. The purchases occurred on June 8, 2026, with prices ranging from £330.5000 to £335.0000 per share, and a volume-weighted average price of £331.9552. Following these transactions, Haleon's registered share capital consists of 8,842,187,061 ordinary shares, with 12,025,084 held in treasury. This leaves 8,830,161,977 ordinary shares with voting rights. The company has made a full breakdown of individual trades available via a link to a PDF document and on its investor website. Haleon is a consumer healthcare company focused on everyday health, with brands such as Advil, Centrum, and Sensodyne.